Evidence map›Paper›PMID 39920485›Full record

ArticleHealth economics review2025

Risky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes?

Toni Mora, Rowena Jacobs, Jordi Cid, David Roche

Abstract read
In one paragraph

Article in Health economics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Toni MoraResearch Institute for Evaluation and Public Policies (IRAPP), Universitat Internacional de Catalunya (UIC), Barcelona, Spain. tmora@uic.es.ORCID http://orcid.org/0000-0002-2686-5307
Rowena JacobsCenter for Health Economics (CHE), University of York, York, UK.ORCID http://orcid.org/0000-0001-5225-6321
Jordi CidInstitut d'Assistència Sanitària (IAS) and Mental Health & Addiction Research Group (IDIBGI), Girona, Spain.ORCID http://orcid.org/0000-0002-6406-0585
David RocheResearch Institute for Evaluation and Public Policies (IRAPP), Universitat Internacional de Catalunya (UIC), Barcelona, Spain.ORCID http://orcid.org/0000-0002-7524-4590

Funding

Ministerio de Ciencia e Innovación PID2021-124067OB-C21
6 · The paper itself

Abstract

backgroundAttention-Deficit/Hyperactivity Disorder (ADHD) prevalence rates are around 5-10% of school-aged children. We test whether medication use for ADHD decreases the likelihood of risky behaviour (sexual behaviour, alcohol, tobacco, and drug consumption) and injuries amongst children aged 6-18.

methodsWe use a large administrative dataset for the whole population of Catalan children in Spain who were born between 1998 and 2012. We apply a scale that contains alternative definitions of ADHD so that over-diagnosis is also identified and estimate a count data model to explain the number of visits whilst accounting for confounding. Our identification strategy relies on instrumenting medication using an average indicator of the probability of prescribing medication for each most visited healthcare centre provider.

resultsOur results suggest that medication use significantly reduced the number of visits of children diagnosed with ADHD for injuries but not risky behaviour. This finding is robust irrespective of the considered span or the grace period after including ADHD-related comorbidities as controls.

conclusionIn line with previous literature, medication use amongst children with ADHD reduces the prevalence of injuries but not risky behaviours.

Indexed as

ADHDDiagnosisHealth outcomesInjuriesPharmacological treatmentRisky behaviour

Identifiers

PMID39920485
PMCPMC11806674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.